FIELD: medicine.
SUBSTANCE: composition includes at least three oligonucleotide probes and enables simultaneously determining a level of PSMB4, FCER2 and POU2F2 genes expression. The oligonucleotide composition under the invention is presented to be used, including as a part of a microchip, in a method for prediction of a developing disease in a subject suffering chronic lymphatic leukemia that involves analysing a level of expression of at least three named genes in patient's blood samples.
EFFECT: higher efficacy of the composition.
8 cl, 5 dwg, 16 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GENE INVOLVED IN IMMORTALISATION OF HUMAN CANCER CELL AND USE THEREOF | 2007 |
|
RU2449016C2 |
| ANALYSES AND METHODS WITH APPLICATION OF BIOMARKERS | 2005 |
|
RU2431676C2 |
| COMPOSITIONS, DIAGNOSTIC TECHNIQUES AND METHOD OF TREATING RENAL DISORDERS IN DOGS | 2010 |
|
RU2546016C2 |
| METHOD FOR DETERMINING LUNG CANCER CELL SENSITIVITY TO CISPLATIN APPLYING MARKER GENE EXPRESSION PATTERN AND SET FOR IMPLEMENTING IT | 2013 |
|
RU2557976C2 |
| DETECTION METHOD OF INTESTINE INFLAMMATORY DISEASE | 2008 |
|
RU2502806C2 |
| MTS GENE, MUTATIONS OF THIS GENE AND METHODS OF DIAGNOSIS OF MALIGNANT TUMORS USING MTS GENE SEQUENCE | 1995 |
|
RU2164419C2 |
| METHOD FOR ANALYSING DISORDERS RELATED TO OVARIAN CARCINOMA | 2008 |
|
RU2511408C2 |
| COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING ASTHMA | 2009 |
|
RU2607569C2 |
| METHODS FOR PREDICTING PROSTATE CANCER | 2016 |
|
RU2760577C2 |
| METHOD FOR DIAGNOSING COLORECTAL CANCER FROM HUMAN FECES SAMPLE BY QUANTITATIVE PCR, PRIMERS AND KIT | 2015 |
|
RU2692555C2 |
